CIK 0001615219
- Non-accelerated filer
- Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465087339
- Phone
- +1 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 44 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-10 | McVicar William K. Director | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2019-09-10 | HANISH ARNOLD C Director | Grant or award · Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2019-01-09 | Boston Foundation, Inc. 10% owner | Sale | −337,000 | $0.37 | $124K | 1,600,000 |
| 2019-01-08 | Boston Foundation, Inc. 10% owner | Sale | −263,000 | $0.40 | $104K | 1,937,000 |
| 2018-10-16 | Longwood Fund II, L.P. 10% owner | Sale | −3,212,861 | $0.92 | $2.9M | 0 |
| 2018-10-16 | Westphal Christoph H 10% owner | Sale | −3,212,861 | $0.92 | $2.9M | 0 |
| 2018-07-25 | RANDLE STUART A Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-07-25 | KOZIN MARC D Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-07-25 | Stacy Michelle Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-07-25 | Tung Roger D Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-07-25 | HUTT PETER BARTON Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-06-14 | McCabe John P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +179,848 | 179,848 | ||
| 2018-06-14 | McVicar William K. President and CEO | Grant or award · Stock Option (right to buy) | +359,696 | 359,696 | ||
| 2018-01-17 | McVicar William K. President and CEO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2018-01-17 | Woo Elizabeth SVP, Investor Relations | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-01-17 | McCabe John P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-01-17 | Wessel Thomas Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2017-11-08 | Tung Roger D Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-07-26 | PEREZ ROBERT J Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-07-26 | Westphal Christoph H Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 |
Page 7 of 12 · 229 trades